Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2014

Open Access 01-12-2014 | Case report

Percutaneous closure of large VSD using a home-made fenestrated atrial septal occluder in 18-year-old with pulmonary hypertension

Authors: Hacer Kamali, Turkay Saritas, Abdullah Erdem, Celal Akdeniz, Volkan Tuzcu

Published in: BMC Cardiovascular Disorders | Issue 1/2014

Login to get access

Abstract

Background

Hemodynamically significant muscular ventricular septal defects in children after the infantile period are a rare occurrence and ideal for transcatheter closure. In cases of severe concomitant pulmonary hypertension, it may be necessary to fenestrate the device. In this report, we present an 18-year old patient with a large mid-trabecular ventricular septal defect and severe pulmonary hypertension that underwent percutaneous closure of the defect with a home-made fenestrated atrial septal occluder.

Case presentation

An 18-year-old female patient referred to us with complaints of dyspnea (NYHA score of 2–3). Physical examination revealed an apical rumble and a harsh second heart sound. Echocardiographic examination revealed a large mid-trabecular ventricular septal defect with bidirectional shunt and the widest diameter measuring 22 mm on 2D echocardiography. Left and right heart cavities were enlarged. Before and after the vasoreactivity test performed during cardiac catheterization, average aortic pressure was 65 → 86 mmHg, average pulmonary artery pressure: 58 → 73 mmHg, Qp/Qs: 1.6 → 3.2, PVR: 4.6 → 4.3 Wood/U/m2 and PVR/SVR: 0.5 → 0.2. On left-ventricular angiocardiogram, the largest end-diastolic defect diameter was 21 mm. The closure procedure was performed with transthoracic echocardiographic guidance, using a 24 mm Cera septal occluder and a 14 F sheath dilator to make a 4.5-5 mm opening. Measured immediately after the procedure and during cardiac catheterization one month later, average aortic pressure was 75 → 75 mmHg, average pulmonary artery pressure: 66 → 30 mmHg, Qp/Qs 1.5 → 1.4, PVR: 4.4 → 2.9 Wood/U/m2 and PVR/SVR: 0.4 → 0.2. Transthoracic echocardiographic examination performed 24 hours after the procedure showed a max 35–40 mmHg gradient between the left and right ventricles through the fenestration. After the procedure, we observed sporadic early ventricular systoles and a nodal rhythm disorder that started after approximately 12 hours and spontaneously reverted to normal 9 days later.

Conclusion

In patients with large ventricular septal defects, large atrial septal occluders may be used. In cases with risk of pulmonary vascular disease, a safer option would be to close the defect using a manually fenestrated device.
Appendix
Available only for authorised users
Literature
1.
go back to reference Arora R, Trehan V, Thakur AK, Mehta V, Sengupta PP, Nigam M: Transcatheter closure of congenital muscular ventricular septal defect. J Interv Cardiol. 2004, 17: 109-115. 10.1111/j.1540-8183.2004.09872.x.CrossRefPubMed Arora R, Trehan V, Thakur AK, Mehta V, Sengupta PP, Nigam M: Transcatheter closure of congenital muscular ventricular septal defect. J Interv Cardiol. 2004, 17: 109-115. 10.1111/j.1540-8183.2004.09872.x.CrossRefPubMed
2.
go back to reference Baspinar O, Irdem A, Kilinc M: Off-label use of Amplatzer devices in congenital heart disorders during childhood. Acta Cardiol. 2013, 68: 31-35.PubMed Baspinar O, Irdem A, Kilinc M: Off-label use of Amplatzer devices in congenital heart disorders during childhood. Acta Cardiol. 2013, 68: 31-35.PubMed
3.
go back to reference Marinakis A, Vydt T, Dens J, Gewillig M, Van Deyk K, Budts W: Percutaneous transcatheter ventricular septal defect closure in adults with Amplatzer septal occluders. Acta Cardiol. 2007, 62: 391-395. 10.2143/AC.62.4.2022283.CrossRefPubMed Marinakis A, Vydt T, Dens J, Gewillig M, Van Deyk K, Budts W: Percutaneous transcatheter ventricular septal defect closure in adults with Amplatzer septal occluders. Acta Cardiol. 2007, 62: 391-395. 10.2143/AC.62.4.2022283.CrossRefPubMed
4.
go back to reference Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM: Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol. 2004, 43: 1257-1263. 10.1016/j.jacc.2003.10.047.CrossRefPubMed Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM: Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol. 2004, 43: 1257-1263. 10.1016/j.jacc.2003.10.047.CrossRefPubMed
5.
go back to reference Dell’avvocata F, Rigatelli G, Cardaioli P, Giordan M: Home-made fenestrated amplatzer occluder for atrial septal defect and pulmonary arterial hypertension. J Geriatr Cardiol. 2011, 8: 127-129. 10.3724/SP.J.1263.2011.00127.CrossRefPubMedPubMedCentral Dell’avvocata F, Rigatelli G, Cardaioli P, Giordan M: Home-made fenestrated amplatzer occluder for atrial septal defect and pulmonary arterial hypertension. J Geriatr Cardiol. 2011, 8: 127-129. 10.3724/SP.J.1263.2011.00127.CrossRefPubMedPubMedCentral
6.
go back to reference Michel-Behnke I, Le TP, Waldecker B, Akintuerk H, Valeske K, Schranz D: Percutaneous closure of congenital and acquired ventricular septal defects–considerations on selection of the occlusion device. J Interv Cardiol. 2005, 18: 89-99. 10.1111/j.1540-8183.2005.04051.x.CrossRefPubMed Michel-Behnke I, Le TP, Waldecker B, Akintuerk H, Valeske K, Schranz D: Percutaneous closure of congenital and acquired ventricular septal defects–considerations on selection of the occlusion device. J Interv Cardiol. 2005, 18: 89-99. 10.1111/j.1540-8183.2005.04051.x.CrossRefPubMed
7.
go back to reference Fu YC: Transcatheter device closure of muscular ventricular septal defect. Pediatr Neonatol. 2011, 52: 3-4. 10.1016/j.pedneo.2010.12.012.CrossRefPubMed Fu YC: Transcatheter device closure of muscular ventricular septal defect. Pediatr Neonatol. 2011, 52: 3-4. 10.1016/j.pedneo.2010.12.012.CrossRefPubMed
8.
go back to reference Rohit MK, Gupta A: Transcatheter closure of large patent ductus arteriosus using custom made devices. Catheter Cardiovasc Interv. 2014, 00: 00-00. Rohit MK, Gupta A: Transcatheter closure of large patent ductus arteriosus using custom made devices. Catheter Cardiovasc Interv. 2014, 00: 00-00.
9.
go back to reference Suh WM, Kern MJ: Transcatheter closure of a traumatic VSD in an adult requiring an ASD occluder device. Catheter Cardiovasc Interv. 2009, 74: 1120-1125. 10.1002/ccd.22141.CrossRefPubMed Suh WM, Kern MJ: Transcatheter closure of a traumatic VSD in an adult requiring an ASD occluder device. Catheter Cardiovasc Interv. 2009, 74: 1120-1125. 10.1002/ccd.22141.CrossRefPubMed
10.
go back to reference Rao PS, Raju V, Narayana M: Flap valved closure of ventricular septal defects with increased pulmonary vascular resistance. Interact Cardiovasc Thorac Surg. 2010, 11: 577-580. 10.1510/icvts.2010.243865.CrossRefPubMed Rao PS, Raju V, Narayana M: Flap valved closure of ventricular septal defects with increased pulmonary vascular resistance. Interact Cardiovasc Thorac Surg. 2010, 11: 577-580. 10.1510/icvts.2010.243865.CrossRefPubMed
11.
go back to reference Bruch L, Winkelmann A, Sonntag S, Scherf F, Rux S, Grad MO, Kleber FX: Fenestrated occluders for treatment of ASD in elderly patients with pulmonary hypertension and/or right heart failure. J Interv Cardiol. 2008, 21: 44-49. 10.1111/j.1540-8183.2007.00324.x.CrossRefPubMed Bruch L, Winkelmann A, Sonntag S, Scherf F, Rux S, Grad MO, Kleber FX: Fenestrated occluders for treatment of ASD in elderly patients with pulmonary hypertension and/or right heart failure. J Interv Cardiol. 2008, 21: 44-49. 10.1111/j.1540-8183.2007.00324.x.CrossRefPubMed
12.
go back to reference Chessa M, Carminati M, Cao QL, Butera G, Giusti S, Bini RM, Hijazi ZM: Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J Invasive Cardiol. 2002, 14: 322-327.PubMed Chessa M, Carminati M, Cao QL, Butera G, Giusti S, Bini RM, Hijazi ZM: Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J Invasive Cardiol. 2002, 14: 322-327.PubMed
13.
go back to reference Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL: Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations. Catheter Cardiovasc Interv. 2000, 49: 167-172. 10.1002/(SICI)1522-726X(200002)49:2<167::AID-CCD11>3.0.CO;2-S.CrossRefPubMed Hijazi ZM, Hakim F, Al-Fadley F, Abdelhamid J, Cao QL: Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations. Catheter Cardiovasc Interv. 2000, 49: 167-172. 10.1002/(SICI)1522-726X(200002)49:2<167::AID-CCD11>3.0.CO;2-S.CrossRefPubMed
14.
go back to reference Butera G, Chessa M, Carminati M: Percutaneous closure of ventricular septal defects. Cardiol Young. 2007, 17: 243-253.CrossRefPubMed Butera G, Chessa M, Carminati M: Percutaneous closure of ventricular septal defects. Cardiol Young. 2007, 17: 243-253.CrossRefPubMed
Metadata
Title
Percutaneous closure of large VSD using a home-made fenestrated atrial septal occluder in 18-year-old with pulmonary hypertension
Authors
Hacer Kamali
Turkay Saritas
Abdullah Erdem
Celal Akdeniz
Volkan Tuzcu
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2014
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/1471-2261-14-74

Other articles of this Issue 1/2014

BMC Cardiovascular Disorders 1/2014 Go to the issue